Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma by Wu, Chunyan et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of
patients with cortisol-producing adenoma
Wu, Chunyan; Zhang, Huijian; Zhang, Jiajun; Zhang, Hongbin; Zeng, Yanmei; Fang, Shu; Li,
Ping; Zhang, Yudan; Lin, Xiaochun; Wang, Ling; Xue, Yaoming; Guan, Meiping
Published in:
Adipocyte
DOI:
10.1080/21623945.2019.1690834
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Wu, C., Zhang, H., Zhang, J., Zhang, H., Zeng, Y., Fang, S., ... Guan, M. (2019). Increased oxidative stress,
inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma. Adipocyte,
8(1), 347-356. https://doi.org/10.1080/21623945.2019.1690834
Download date: 03. Feb. 2020
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=kadi20
Adipocyte
ISSN: 2162-3945 (Print) 2162-397X (Online) Journal homepage: https://www.tandfonline.com/loi/kadi20
Increased oxidative stress, inflammation and
fibrosis in perirenal adipose tissue of patients with
cortisol-producing adenoma
Chunyan Wu, Huijian Zhang, Jiajun Zhang, Hongbin Zhang, Yanmei Zeng,
Shu Fang, Ping Li, Yudan Zhang, Xiaochun Lin, Ling Wang, Yaoming Xue &
Meiping Guan
To cite this article: Chunyan Wu, Huijian Zhang, Jiajun Zhang, Hongbin Zhang, Yanmei Zeng,
Shu Fang, Ping Li, Yudan Zhang, Xiaochun Lin, Ling Wang, Yaoming Xue & Meiping Guan (2019)
Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with
cortisol-producing adenoma, Adipocyte, 8:1, 347-356, DOI: 10.1080/21623945.2019.1690834
To link to this article:  https://doi.org/10.1080/21623945.2019.1690834
© 2019 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 13 Nov 2019.
Submit your article to this journal Article views: 150
View related articles View Crossmark data
RESEARCH PAPER
Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue
of patients with cortisol-producing adenoma
Chunyan Wua, Huijian Zhangb, Jiajun Zhangc, Hongbin Zhangd, Yanmei Zenga, Shu Fanga, Ping Lia,
Yudan Zhang a, Xiaochun Lina, Ling Wanga, Yaoming Xuea, and Meiping Guana
aDepartment of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China; bDepartment of Urology,
Nanfang Hospital, Southern Medical University, Guangzhou, China; cDepartment of Radiology, National Cancer Center/National Clinical
Research Center for Cancer/Cancer Hospital & Shenzhen Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College,
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ABSTRACT
Although much is known about that corticosteroids affect the functions of adipose tissues, little
genetic information is available for perirenal adipose tissue (peri-N) from patients with cortisol-
producing adenoma (CPA). We conducted microarray analysis of peri-N from patients with CPA by
using an Affymetrix human U133 plus 2.0 array. We also analysed the inflammation, fibrosis and
oxidative stress in vitro. Compared with normotension (NT) group, CPA group has significantly higher
protein levels of TNFα, IL-6, fibronectin (FN) and collagen I (COLI). The protein level of NADPH oxidase
4 (Nox4) significantly increased, while nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeox-
ygenase-1 (HO-1) levels were significantly reduced in the CPA group. Dexamethasone markedly
induced fibrosis and adipogenesis-related gene expression in predifferentiated stromal vascular
fraction (SVF) cells, 3T3-L1 preadipocytes and brown preadipocytes. Chronic exposure to endogenous
glucocorticoids due to CPA increases peri-N oxidative stress, inflammation and fibrosis, which may
contribute to the metabolic disturbances associated with hypercortisolism in these patients.
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Introduction
Patients with Cushing’s syndrome (CS) often suffer from
a series of complications such as impaired glucose toler-
ance, dyslipidemia and cardiovascular disease (CVD) [1,2].
A previous study showed that themortality in patients with
CS still increased despite the aetiology treatment [3].
However, the relevant mechanisms remain unclear.
A recent study showed that perirenal adipose tissue (peri-
N) from patients with active Cushing’s disease exhibits an
increased number of pro-inflammatorymacrophages com-
pared to body mass index (BMI) matched controls [4].
Whether endogenous hypercortisolism can lead to peri-N
dysfunction in patients with CPA remains unclear. Peri-N
was showed brown adipose tissue (BAT) characterization
[5]. Our previous study [6] reported that high aldosterone
levels in patientswith primary aldosteronismdue to adrenal
adenoma induced peri-N inflammation and fibrosis and let
to dysfunction. A comprehensive assessment of perirenal
fat frompatients with CPA is still lacking. Very little genetic
information about peri-N inCPA is available. In the current
study, RNA sequencing of perirenal fat in CPApatients was
performed by using gene microarray. Adipose tissue
oxidative stress can promote adipose tissue inflammation
and inappropriate extracellular matrix remodelling in obe-
sity [7], however, data of peri-N characteristics from
patients with CPA are lacking.We also examined oxidative
stress, inflammation and fibrosis in peri-N from CPA
patients, SVF cells, 3T3-L1 and brown preadipocytes.
Patients and methods
Patients
Peri-N and sub-Q were sampled from 8 patients with
benign CPA undergoing laparoscopic adrenalectomy, 4
patients with essential hypertension (EH) and 10
patients with NT undergoing nephrolithotomy or ure-
terolithotomy. The diagnosis of Cushing’s syndrome
was made according to guidelines [8]. CPA was diag-
nosed according to clinical characteristics, biochemical
assessment, adrenal glands computed tomography scan
and histopathology. Serum cortisol, 24h urinary free
cortisol and adrenocorticotropic hormone were used
for initial screening. The 1mg dexamethasone suppres-
sion test (DST) and 8mg high-dose DST were used for
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subsequent diagnosis of CPA. All CPA patients were in
active disease and did not receive reduce hypercortiso-
lemia treatment before surgery. The ethics committee
of Nanfang Hospital approved this study. .All indivi-
dual participants provided written informed consent.
Gene expression profile of peri-N in patients with
CPA and EH
Gene expression in peri-N of 5 patients with CPA and 4
patients with EH was measured by using Affymetrix HG
U133 plus 2.0 arrays. The characteristics of the patients
included in the gene expression analyses are showed in
Table 1.
Quantitative real-time PCR and western blotting
Peri-N and sub-Q from patients with CPA (n = 8) and
patients with NT (n = 10) were used for validation experi-
ments. The characteristics of the patients included in the
validation experiment are described in Table 2. Adipose
tissue total RNA was extracted by using Trizol (TAKARA)
and used for cDNA synthesis using Prime Script RT
Reagent Kit (TAKARA). The quantitative real-time PCR
(qRT-PCR) was run on Roche LightCycler 480 Real-Time
PCRSystem.Gene expression levels of inflammation, fibro-
sis, oxidative stress and adipogenesis marker genes was
analysed by qRT-PCR.Arbp (38B4) served as housekeeping
gene in mouse brown preadipocytes and 3T3-L1 preadipo-
cytes. 18S were used as housekeeping gene in human SVF
cells and adipose tissue. Gene expression levels of inflam-
mation, fibrosis, oxidative stress and adipogenesis marker
genes were measured by qRT-PCR. Western blot was car-
ried out as previously described [9]. For the analysis of total
protein in peri-N, antibodies specific for interleukin-6 (Cell
Signalling Technology, #12,153), HO-1 (Abclonal, A1346),
NOX4 (Abclonal, A11274) and Nrf2 (Santa Cruz, sc-722)
were used. For the analysis of nuclear protein in perirenal
adipose tissue, antibodies for phospho-NF-κB p65 (Cell
Signalling Technology, #3033) and NF-κB p65 (Cell
Signalling Technology, #8242) were used. β-acitn and his-
tone-H3 were used as total protein and nuclear protein
loading controls, respectively.
Immunohistochemistry and Masson’s staining
Immunohistochemical stains of TNF-α (Abcam, ab6671),
FN (Abcam, ab23751), COLI (Abcam, ab6308) and CD68
Table 1. Clinical and biochemical feature of the patients.
Parameter Essential hypertension Cushing’s syndrome P value
n 4 5
Sex(M/F) 4/0 0/5
Age(year) 54.25 ± 7.97 36.80 ± 14.52 NS
Body mass index(kg/m2) 24.59 ± 2.99 26.33 ± 5.36 NS
Systolic blood pressure(mmHg) 143.50 ± 17.25 131.80 ± 14.58 NS
Diastolic blood pressure(mmHg) 89.50 ± 5.45 95.40 ± 9.29 NS
Fasting glucose(mmol/L) 5.25 ± 0.40 5.84 ± 1.76 NS
White blood cell count (109/L) 7.44 ± 1.55 9.55 ± 1.67 NS
Alanine transaminase (U/L) 25.00 ± 9.055 31.40 ± 18.03 NS
Glutamic-oxal(o)acetic transaminase (U/L) 24.5 ± 4.04 24.4 ± 16.04 NS
Morning plasma cortisol levels (µg/dl) 23.08 ± 6.89
(normal value, 4.3–22.4)
Midnight plasma cortisol levels (µg/dl) 22.59 ± 3.08
(normal value, 3.9–16.66)
All data are shown as mean ± Standard Deviation. NS, Not significant.
Table 2. Clinical and biochemical feature of the patients.
Parameter Normotensive patients Cushing’s syndrome P value
n 10 8
Sex(M/F) 5/5 1/7 NS
Age(year) 47.20 ± 15.80 40.13 ± 13.64 NS
Body mass index(kg/m2) 22.48 ± 2.74 26.96 ± 4.30 0.016
Systolic blood pressure(mmHg) 123.33 ± 12.86 136.63 ± 14.29 NS
Diastolic blood pressure(mmHg) 74.6 ± 10.41 92.88 ± 9.57 0.001
Fasting glucose(mmol/L) 5.06 ± 0.49 5.96 ± 1.79 NS
White blood cell count (109/L) 7.53 ± 2.66 10.15 ± 2.38 0.045
Creatinine (µmol/L) 95.7 ± 64.25 63.88 ± 6.89 NS
Alanine transaminase (U/L) 20.8 ± 8.19 32.63 ± 21.39 NS
Glutamic-oxal(o)acetic transaminase (U/L) 22.1 ± 12.32 23 ± 12.52 NS
Morning plasma cortisol levels (µg/dl) 24.09 ± 5.68
(normal value, 4.3–22.4)
Midnight plasma cortisol levels (µg/dl) 23.37 ± 3.79
(normal value, 3.9–16.66)
All data are shown as mean ± Standard Deviation. NS, Not significant.
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(Abcam, ab955) was performed on paraffin-embedded
specimens of peri-N from CPA and NT patients as
described previously [10]. In addition, peri-N paraffin
sections were also performed with Masson’s stain as
described before [10].
Cell culture
Mouse 3T3-L1 preadipocyteswere purchased from the type
culture collection of the Chinese Academy of Sciences.
Mouse brown preadipocytes were established as previously
described [11,12]. Cells were isolated from the SVF of peri-
N and sub-Q from CPA patients as described previously
[13]. Human peri-N and sub-Q were obtained from a 26-
year-old female with benign CPA who undertook laparo-
scopic adrenalectomy. She was 156cm in height and
weighed 58kg, and she had typical signs of Cushing’s syn-
drome, such as a moon face, hirsutism, central obesity and
purple striae. Biochemical examination revealed a loss of
the diurnal circadian rhythm in serum cortisol levels, an
increase of 24 hour urinary free cortisol and suppressed
ACTH level. Low- and high-dose dexamethasone admin-
istration unable to suppress the cortisol level. Computed
tomography of adrenal revealed 27mmx 23mm left adrenal
nodule. Cells were grown in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% foetal bovine
serum. Preadipocytes were incubated in serum-free
DMEM for 12 hours before treatment. Then, the cells
were treated with dexamethasone or vehicle (Sigma,
D4902) for 24 hours.
Statistical analysis
The Student’s t test was performed to analyse normally
distributed data, and results were expressed as mean ±
standard error. Abnormally distributed data were ana-
lysed used the Wilcoxon signed-ranks test.
Results
Gene expression in peri-N from CPA patients
In an effort to identify the characteristics of peri-N in
CPA patients, samples from EH patients (n = 4) and
CPA patients (n = 5) were analysed by microarray
(Table 1).
Microarray mRNA expression profiles data revealed
dysregulated genes associated with inflammation, fibro-
sis and lipid metabolism (Figure 1(a)). PANTHER
pathway analysis identified signalling mainly associated
with inflammation and fibrosis (Figure 1(b)). Volcano
plot show differential gene expression profiles in peri-N
adipose tissue from patients with CPA compared with
patients with EH (Figure 1(c)).
Clinical characteristics and biochemical
measurements in patients with CPA and NT
The characteristics of the patients are described in
Table 2. CPA patients had higher white blood cell
count, body mass index and diastolic blood pressure
than normotensive subjects. Plasma adrenocorticotro-
pic hormone (ACTH) in CPA patients was lower than
1.24 pg/ml (normal value, 7.2–63.3 pg/ml). Urinary free
cortisol in CPA patients exceeded 825 µg/24h (normal
value, 20.9–292.3 µg/24 h).
Upregulation of inflammation and fibrosis
infiltration in peri-N from patients with CPA
To confirm the microarray data, gene expression was
further analysed in the peri-N of CPA patients and
controls (NT group). Both mRNA and protein levels
of IL-6 and TNF-α were substantially increased in peri-
N from CPA patients compared with those in controls
(Figure 2(a,b)). The number of macrophage cell specific
marker CD68 positive cells observed was notably
higher in the peri-N of CPA patients than in the peri-
N of controls (Figure 2(b)). The mRNA expression
levels of IL-6 and TNF-α was higher in sub-Q of CPA
patients than in that of controls (Figure 2(c)).
Immunohistochemical analysis demonstrated that FN
and COLI protein expression levels were markedly
increased in the peri-N of CPA patients compared
with those in the peri-N of controls (Figure 3(a)).
Accordingly, Masson’s staining also revealed that
there was more collagen deposition in the peri-N of
CPA patients than in the peri-N of controls (Figure 3
(a)). Expression of FN, COLI, tissue inhibitor of metal-
loproteases 1 (TIMP1) and transforming growth factor-
β1 (TGFβ1) mRNA was further detected. The mRNA
levels of TIMP1, FN and COLI were markedly
increased in the peri-N of CPA patients (Figure 3(b)).
In subcutaneous adipose tissue, the levels of fibrosis-
related genes including FN, COLI and TIMP1, were
remarkably higher in the CPA patients compared with
those in the NT patients (Figure 3(c)).
Increased oxidative stress in peri-N from patients
with CPA
Oxidative stress was analysed in the peri-N of CPA
patients. Real time RT-PCR demonstrated that NOX4,
glutathione peroxidase 4 (Gpx4) and cytochrome b-245
alpha chain (CYBA) mRNA expression levels were
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upregulated in both peri-N and subcutaneous adipose
tissue from CPA patients compared with controls
(Figure 4(c,d)). In contrast, Nrf2 mRNA expression was
substantially decreased in both peri-N and subcutaneous
adipose tissue in CPA patients (Figure 4(c,d)). Similarly,
Western blot showed that NOX4 levels significantly
increased, while Nrf2 and HO-1 protein levels were sig-
nificantly reduced in CPA patients (Figure 4(a)). To
explore the role of NF-κB, the nuclear protein levels of
phospho-NF-κB and NF-κB in peri-N were analysed by
Western blot. As showed in (Figure 4(b)), NF-κB and
phospho-NF-κB levels were upregulated in the CPA
patients compared with control patients, indicating that
NF-κB was activated in the peri-N of CPA patients.
Effect of dexamethasone on mRNA levels related to
adipokines and fibrosis in 3T3-L1 and brown
preadipocytes
To further investigate changes in the function of adipose
tissue in CPA patients, we evaluated adipokine markers in
peri-N and subcutaneous adipose tissue. Compared with
NT group, CCAAT/enhancer binding protein alpha (C/
EBPα) and CCAAT/enhancer binding protein beta (C/
EBPβ) mRNA levels in peri-N was significantly decreased
in the CPA group (Figure 5(a)), whereas peroxisome
proliferator activated receptor gamma (PPARγ), C/EBPα
and PPARγ coactivator 1 alpha (PGC1α) mRNA levels
was remarkably increased in sub-Q of CPA group (Figure
5(b)). To investigate the effect of dexamethasone on adi-
pocytes, mouse 3T3-L1 preadipocytes and brown preadi-
pocytes were treated with dexamethasone. As showed in
Figure 5(c,f), dexamethasone significantly increased
PPARγ, CIDEA and C/EBPα mRNA levels in 3T3-L1
preadipocytes and brown preadipocytes. Higher UCP1
and PGC1α mRNA expression levels were observed
after dexamethasone treatment in brown preadipocytes
than in controls (Figure 5(e)). Moreover, dexamethasone
induced increase mRNA levels of genes related to fibrosis,
including alpha-smooth muscle actin (α-SMA), FN and
COLI, in 3T3-L1 and brown preadipocytes (Figure 5(d,f)).
Isolation of SVF cells from peri-N and sub-Q from
CPA patient and adipocyte culture in vitro
To determine the effect of dexamethasone on SVF cell
characteristics and functions, primary preadipocytes
were isolated from one CPA patient’s paired
Figure 1. Gene expression profile of peri-N in patients with CPA and EH.
(a) Heat map of genes related to lipid metabolism inflammation and fibrosis in peri-N between patients with EH and patients with CPA (fold
change > 2.0 or fold change < −0.4; q value<0.05). EH, essential hypertension; CPA, cortisol-producing adenoma; peri-N, perirenal adipose
tissue. (b) Pathway analysis showed the most typical pathways in CPA and EH samples. (c) Volcano plot showed differentially expressed
genes in peri-N fat from patients with CPA compared with patients with EH. Green symbolizes markedly downregulated genes, and red
symbolizes markedly upregulated genes. (fold change ≥2 and p value≤0.05). peri-N, perirenal adipose tissue.
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subcutaneous and peri-N (Figure 6(a,d)). Next, predif-
ferentiated perirenal and subcutaneous fat SVF cells
were treated with dexamethasone (0.5 µM) for
24 hours to examine the mRNA levels of genes asso-
ciated with adipokines and fibrosis. Dexamethasone
remarkably increased PPARγ, PGC1α, C/EBPα and C/
EBPβmRNA expression in predifferentiated CPA sub-Q
SVF cells and induced a remarkable increase in FN and
early growth response factor-1 (EGR1) mRNA expres-
sion (Figure 6(b,c)). Dexamethasone significantly
increased PPARγ, C/EBPα, FN and EGR1 mRNA levels
in peri-N SVF cells from this CPA patient (Figure 6(e,f)).
Discussion
In this study, we explored peri-N changes induced by
chronic endogenous hypercortisolism due to CPA.
We found that oxidative stress, inflammation and
fibrosis are notably changed in response to chronic
hypercortisolism exposure in patients with CPA, and
Figure 2. Inflammation change in peri-N from patients with CPA.
(a) IL-6 protein expression was detected by Western blot in peri-N from patients with CPA (n = 6) compared with normotension
patients(n = 6). (b) TNF-αand CD68 protein expression in peri-N of patients with CPA (n = 5) and controls (n = 5)was assessed by
immunohistochemistry (×400). Scale bar, 50 µm. (c, d), IL-6 and TNF-α gene expression in peri-N and sub-Q. NT, normotension,
n = 10; CPA, cortisol-producing adenoma, n = 8. sub-Q, subcutaneous adipose tissue. *P < 0.05 vs normotension subjects.
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these features may be involved in adverse metabolic
effects.
Adipose tissue fibrosis and inflammation exert an
equally important impact on cardiovascular disease
[14,15]. A previous study [16] showed that dexametha-
sone inhibited high fat diet (HFD)-fed mice epididymal
adipose tissue macrophages accumulation. The authors
also reported [16] that dexamethasone inhibited macro-
phage recruitment in mature 3T3-L1 cells. The plasma
IL-6 level of patients with Cushing’s syndrome was
increased compared with normal controls [17].
Researchers have found that, despite long-term cure,
plasma inflammation markers, including TNF alpha-
receptor 1 and IL-6, were higher in Cushing’s syn-
drome patients than in matched healthy controls [18].
Although much is known that acute corticosteroid
therapy exerts anti-inflammatory effects [19], little is
known about local adipose tissue changes in patients
with CPA. Recent research has reported an increased
adipose tissue macrophage presence in active Cushing’s
Figure 3. Fibrosis infiltration in peri-N from patients with CPA.
(a) Peri-N FN and COLI immunohistochemical and Masson’s staining (×400), NT peri-N, n = 5; CPA peri-N, n = 5. (b) Expression of genes
associated with fibrosis in peri-N from CPA group (n = 8) and normotension group (n = 10). Scale bar, 50 µm. NT, normotension; CPA,
cortisol-producing adenoma. peri-N, perirenal adipose tissue. (c) Expression of fibrosis genes in subcutaneous adipose tissue from CPA and
normotension patients, n = 8. Sub-Q, subcutaneous adipose tissue, n = 10. *P < 0.05 vs normotension subjects.**P < 0.01 vs normotension
subjects.
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disease patients [4]. These findings indicated that
chronic exposure to endogenous glucocorticoids may
exacerbate inflammation. Irit et al. [20]reported RNA
sequencing of subcutaneous fat from patients with
Cushing’s disease and non-functioning pituitary adeno-
mas as controls, and the results showed down-regulated
expression of transcripts involved in immune function
in the Cushing’s disease group. In the current study,
our results showed that IL-6 and TNF-α levels were
remarkably higher in peri-N from patients with CPA
compared with those in patients with NT, which indi-
cated increased inflammation in peri-N from patients
with CPA. In addition, in accordance with a previous
study [4,21], CD68 positive cells observed was
increased in peri-N from patients with CPA compared
with that in peri-N from patients with NT.
Henegar et al. [22] found dysregulation of many
extracellular matrix components in sub-Q from obese
subjects compared with lean subjects. Adipose tissue
fibrosis is associated with adipose tissue dysfunction
[23]. Our results demonstrated that fibrosis in the
peri-N of CPA patients was significantly increased,
and genes related to fibrosis were also increased in
the sub-Q of CPA patients.
Compared with EH and normotension patients, subcu-
taneous adipose tissue oxidative stress was increased in
Cushing’s syndrome patients [24]. Houstis and co-
workers reported that protein carbonyl levels were elevated
110% in dexamethasone treated adipocytes [25].A pervious
study also showed persistent metabolic abnormalities dur-
ing long-term remission Cushing’s syndrome patients [26].
Another study found that oxidative stress as measured by
plasma 15-F2t – isoprostane levels was remarkably higher
in patients with Cushing’s syndrome than in healthy sub-
jects [27]. Our results revealed that the expression of NOX4
protein was significantly increased, while expression of
Nrf2 and HO1 proteins was notably decreased in peri-N
frompatientswithCPA.Wealso foundNF-κBactivation in
the peri-N of CPA patients. NF-κB plays an important role
in inflammatory processes associated with oxidative stress
[28]. In the current study, we observed perirenal and sub-
cutaneous adipose tissue dysfunction in CPA patients,
which indicated that endogenous hypercortisolism may
play an important role in local adipose tissue dysfunction.
In conclusion, our study demonstrated that
changes in oxidative stress, inflammation and fibrosis
occur in the peri-N of CPA patients. Peri-N dysfunc-
tion associated with chronic exposure to
Figure 4. Increased oxidative stress in peri-N from patients with CPA.
(a) Western blot analysis of NOX4, Nrf2, HO-1 and β-actin (loading control) protein levels in perirenal adipose tissue; NT peri-N, n = 6; CPA
peri-N, n = 6. (b) Western blot analysis of phospho-NF-κB p65 and NF-κB p65 nuclear protein levels in perirenal adipose tissue. H3 was
served as a protein loading control. (c, d) Expression changes in reactive oxygen species genes in sub-Q and peri-N from patients with CPA
(n = 8) and normotension patients (n = 10). *P < 0.05 vs normotension subjects.
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hypercortisolism may be involved in metabolic dis-
orders in CPA patients.
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